It blocks the proliferation of and induces the differentiation of chronic myeloid leukemia cells with T315I mutation and wild-type BCR-ABL, as observed in colony formation assays. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.